New diabetes clinical trial: Ongericimab Injection Reducing Recurrence of Ischemic Stroke

Published on: November 20, 2025 at 11:00PM
Conditions: Ischemic Cerebral Infarction
Interventions: Combination Product: High target group; Combination Product: Low target group
Sponsors: Beijing Tiantan Hospital
Not yet recruiting
https://ift.tt/H3b7Xmk